BAK1 and breast carcinoma: The ability of MCL-1 inhibitor S63845 to restrict human breast cancer stem cell growth was also negated in the absence of BAX/BAK, clearly illustrating the importance of canonical anti-apoptotic MCL-1 function in breast cancer stem cells (Fig. 5A).